JP2006512077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512077A5 JP2006512077A5 JP2004564004A JP2004564004A JP2006512077A5 JP 2006512077 A5 JP2006512077 A5 JP 2006512077A5 JP 2004564004 A JP2004564004 A JP 2004564004A JP 2004564004 A JP2004564004 A JP 2004564004A JP 2006512077 A5 JP2006512077 A5 JP 2006512077A5
- Authority
- JP
- Japan
- Prior art keywords
- hcv
- cell
- test compound
- absence
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- 238000000034 method Methods 0.000 claims 16
- 208000015181 infectious disease Diseases 0.000 claims 6
- 102100040843 C-type lectin domain family 4 member M Human genes 0.000 claims 5
- 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 claims 5
- 101000749311 Homo sapiens C-type lectin domain family 4 member M Proteins 0.000 claims 5
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 239000010839 body fluid Substances 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000002751 oligonucleotide probe Substances 0.000 claims 2
- 238000011895 specific detection Methods 0.000 claims 2
- 238000002105 Southern blotting Methods 0.000 claims 1
- 210000004381 amniotic fluid Anatomy 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 125000001151 peptidyl group Chemical group 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000003753 real-time PCR Methods 0.000 claims 1
- 238000003757 reverse transcription PCR Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/328,997 US20030232745A1 (en) | 2001-06-26 | 2002-12-24 | Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection |
| PCT/US2003/041093 WO2004058953A1 (en) | 2002-12-24 | 2003-12-22 | Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512077A JP2006512077A (ja) | 2006-04-13 |
| JP2006512077A5 true JP2006512077A5 (enExample) | 2007-02-15 |
Family
ID=32680776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004564004A Withdrawn JP2006512077A (ja) | 2002-12-24 | 2003-12-22 | Ｃ型肝炎ウイルスの感染を阻害するための、ｄｃ−ｓｉｇｎおよびｄｃ−ｓｉｇｎｒの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030232745A1 (enExample) |
| EP (1) | EP1583824A4 (enExample) |
| JP (1) | JP2006512077A (enExample) |
| AU (1) | AU2003299856A1 (enExample) |
| CA (1) | CA2511243A1 (enExample) |
| WO (1) | WO2004058953A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1046651A1 (en) | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| US7022323B2 (en) * | 2001-06-26 | 2006-04-04 | Progenics Pharmaceuticals, Inc. | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| AU2003269389A1 (en) * | 2002-09-20 | 2004-04-08 | Stichting Katholieke Universiteit | Antigen uptake receptor for candida albicans on dendritic cells |
| US7691591B2 (en) * | 2002-09-20 | 2010-04-06 | Stichting Katholieke Universiteit | Methods of identifying and isolating cells expressing DC-sign |
| JP2008504222A (ja) * | 2003-12-15 | 2008-02-14 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 新規の抗ｄｃ−ｓｉｇｎ抗体 |
| ES2349153T3 (es) * | 2004-09-29 | 2010-12-28 | The Administrators Of The Tulane Educational Fund | Inhibidores del virus de la hepatitis c. |
| US8088729B2 (en) * | 2005-12-01 | 2012-01-03 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Anti-viral griffithsin compounds, compositions and methods of use |
| EP2778682A4 (en) * | 2011-11-10 | 2015-05-27 | Kowa Co | METHOD FOR MEASURING A PHYSIOLOGICALLY ACTIVE SUBSTANCE OF BIOLOGICAL ORIGIN |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US184150A (en) * | 1876-11-07 | Improvement in cultivating-harrows | ||
| US300971A (en) * | 1884-06-24 | Carriage-top | ||
| US5679342A (en) * | 1987-11-18 | 1997-10-21 | Chiron Corporation | Hepatitis C virus infected cell systems |
| JPH06504431A (ja) * | 1990-11-08 | 1994-05-26 | カイロン コーポレイション | Ｃ型肝炎ウイルスアシアロ糖タンパク質 |
| ZA927837B (en) * | 1991-10-15 | 1994-03-11 | Akzo Nv | Monoclonal antibodiesto hepatitis C virus |
| US6391567B1 (en) * | 2000-03-02 | 2002-05-21 | New York University | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
-
2002
- 2002-12-24 US US10/328,997 patent/US20030232745A1/en not_active Abandoned
-
2003
- 2003-12-22 AU AU2003299856A patent/AU2003299856A1/en not_active Abandoned
- 2003-12-22 CA CA002511243A patent/CA2511243A1/en not_active Abandoned
- 2003-12-22 WO PCT/US2003/041093 patent/WO2004058953A1/en not_active Ceased
- 2003-12-22 EP EP03800130A patent/EP1583824A4/en not_active Withdrawn
- 2003-12-22 JP JP2004564004A patent/JP2006512077A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2895262T3 (es) | Cuantificación del genoma de anelovirus como biomarcador de la inmunosupresión | |
| JP2010521655A5 (enExample) | ||
| Hapaurachchi et al. | Laboratory confirmation of dengue and chikungunya co-infection | |
| JP2013505007A5 (enExample) | ||
| JP2006512077A5 (enExample) | ||
| WO2003089929A1 (en) | Device, method, and kit for gene detection | |
| WO1991011534A1 (en) | A rapid and sensitive test for detecting hepatitis a virus | |
| Klepper et al. | Hepatitis C virus double‐stranded RNA is the predominant form in human liver and in interferon‐treated cells | |
| KR20230007464A (ko) | 호흡기 병원체 검출을 위한 검체수송 키트 및 이를 이용한 호흡기 병원체 검출방법 | |
| KR20200083444A (ko) | 호흡기 세포융합 바이러스 종의 니킹 및 연장 증폭 반응(near) | |
| CN107209188A (zh) | 用于检测人Pegivirus 2 (HPgV‑2)的组合物和方法 | |
| Rauf et al. | Prevalence of hepatitis B and C virus in the general population of Hill Surang area, Azad Jammu and Kashmir, Pakistan | |
| Elkady et al. | Performance of two Real‐Time RT‐PCR assays for quantitation of hepatitis C virus RNA: Evaluation on HCV genotypes 1–4 | |
| Ciotti et al. | Advances in the diagnosis and monitoring of hepatitis C virus infection | |
| Kim et al. | Exploration of the metal coordination region of concanavalin A for its interaction with human norovirus | |
| US20240271229A1 (en) | Reagents and Methods for Detecting HCV | |
| JP2000325099A (ja) | 新規な核酸ハイブリダイゼーション用緩衝溶液 | |
| Legler et al. | Specific magnetic bead-based capture of free fetal DNA from maternal plasma | |
| US20080125333A1 (en) | Devices and kits for detecting one or more target agents | |
| Fabrizi et al. | Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients | |
| JP2006525351A5 (enExample) | ||
| Katsurada et al. | Circulating antibody to hepatitis B core antigen does NOT always reflect the latent hepatitis B virus infection in the liver tissue | |
| Mukaide et al. | New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2. 0 | |
| US20110104300A1 (en) | Methods for Screening Chemical, Biological, and Physical Agents for Disinfecting Infectious Norovirus | |
| ES2339240T3 (es) | Metodo para detectar y cuantificar el virus de la hepatitis c. |